Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Food Chem Toxicol ; 159: 112663, 2022 Jan.
Article in English | MEDLINE | ID: mdl-34748883

ABSTRACT

Fusaric acid is a secondary metabolite produced by various Fusarium fungi, present with relatively high incidence in Fusarium-contaminated foods. It was already described as phytotoxic and cytotoxic. However, the understanding of its molecular mechanisms is still fragmentary and further data are needed to ensure an informed assessment of the risk related to its presence in food. This work applied an integrated in silico/in vitro approach to reveal novel potential biological activities of fusaric acid and to investigate the underpinning mechanisms. An in silico reverse screening was used to identify novel biological targets for fusaric acid. Computational results indicated as target protein kinase-A, which was confirmed with biochemical cell-free assays providing evidence of its actual inhibitory potential. Cell-based experiments on intestinal cells (HCEC-1CT cells) identified the mitochondrial network and cell membranes as potentially affected organelles, possibly resulting from PKA inhibition. The integration of 3D molecular modeling supported the plausibility of fusaric acid-dependent inhibition. From the hazard identification perspective, considering the Low Observed Adverse Effect Level described here (0.1 mM) and the possible level of contamination in food, fusaric acid might raise concern from a food safety standpoint and the gastrointestinal tract was described as a meaningful system to investigate with priority.


Subject(s)
Cyclic AMP-Dependent Protein Kinases , Drug Development/methods , Fusaric Acid , Mycotoxins , Cell Line, Tumor , Cell Survival/drug effects , Cyclic AMP-Dependent Protein Kinases/antagonists & inhibitors , Cyclic AMP-Dependent Protein Kinases/chemistry , Cyclic AMP-Dependent Protein Kinases/metabolism , Fusaric Acid/chemistry , Fusaric Acid/metabolism , Fusaric Acid/toxicity , Fusarium/metabolism , Humans , Molecular Dynamics Simulation , Mycotoxins/chemistry , Mycotoxins/metabolism , Mycotoxins/toxicity
2.
ACS Infect Dis ; 7(8): 2310-2323, 2021 08 13.
Article in English | MEDLINE | ID: mdl-34329558

ABSTRACT

Reliable antimicrobial susceptibility testing is essential in informing both clinical antibiotic therapy decisions and the development of new antibiotics. Mammalian cell culture media have been proposed as an alternative to bacteriological media, potentially representing some critical aspects of the infection environment more accurately. Here, we use a combination of NMR metabolomics and electron microscopy to investigate the response of Escherichia coli and Pseudomonas aeruginosa to growth in differing rich media to determine whether and how this determines metabolic strategies, the composition of the cell wall, and consequently susceptibility to membrane active antimicrobials including colistin and tobramycin. The NMR metabolomic approach is first validated by characterizing the expected E. coli acid stress response to fermentation and the accompanying changes in the cell wall composition, when cultured in glucose rich mammalian cell culture media. Glucose is not a major carbon source for P. aeruginosa but is associated with a response to osmotic stress and a modest increase in colistin tolerance. Growth of P. aeruginosa in a range of bacteriological media is supported by consumption of formate, an important electron donor in anaerobic respiration. In mammalian cell culture media, however, the overall metabolic strategy of P. aeruginosa is instead dependent on consumption of glutamine and lactate. Formate doping of mammalian cell culture media does not alter the overall metabolic strategy but is associated with polyamine catabolism, remodelling of both inner and outer membranes, and a modest sensitization of P. aeruginosa PAO1 to colistin. Further, in a panel of P. aeruginosa isolates an increase between 2- and 3-fold in sensitivity to tobramycin is achieved through doping with other organic acids, notably propionate which also similarly enhances the activity of colistin. Organic acids are therefore capable of nonspecifically influencing the potency of membrane active antimicrobials.


Subject(s)
Anti-Infective Agents , Pseudomonas aeruginosa , Cell Wall , Escherichia coli , Microbial Sensitivity Tests
3.
Arch Toxicol ; 95(6): 2201-2221, 2021 06.
Article in English | MEDLINE | ID: mdl-33890134

ABSTRACT

Deoxynivalenol (vomitoxin, DON) is a secondary metabolite produced by Fusarium spp. fungi and it is one of the most prevalent mycotoxins worldwide. Crop infestation results not only in food and feed contamination, but also in direct dermal exposure, especially during harvest and food processing. To investigate the potential dermotoxicity of DON, epidermoid squamous cell carcinoma cells A431 were compared to primary human neonatal keratinocytes (HEKn) cells via proteome/phosphoproteome profiling. In A431 cells, 10 µM DON significantly down-regulated ribosomal proteins, as well as mitochondrial respiratory chain elements (OXPHOS regulation) and transport proteins (TOMM22; TOMM40; TOMM70A). Mitochondrial impairment was reflected in altered metabolic competence, apparently combined with interference of the lipid biosynthesis machinery. Functional effects on the cell membrane were confirmed by live cell imaging and membrane fluidity assays (0.1-10 µM DON). Moreover, a common denominator for both A431 and HEKn cells was a significant downregulation of the squalene synthase (FDFT1). In sum, proteome alterations could be traced back to the transcription factor Klf4, a crucial regulator of skin barrier function. Overall, these results describe decisive molecular events sustaining the capability of DON to impair skin barrier function. Proteome data generated in the study are fully accessible via ProteomeXchange with the accession numbers PXD011474 and PXD013613.


Subject(s)
Epidermal Cells/drug effects , Keratinocytes/drug effects , Lipids/biosynthesis , Trichothecenes/toxicity , Carcinoma, Squamous Cell/metabolism , Cell Line, Tumor , Cells, Cultured , Dose-Response Relationship, Drug , Epidermal Cells/pathology , Fusarium/metabolism , Humans , Keratinocytes/pathology , Mitochondria/drug effects , Mitochondria/pathology , Proteomics , Secondary Metabolism , Trichothecenes/administration & dosage , Trichothecenes/isolation & purification
4.
Biomolecules ; 10(7)2020 07 09.
Article in English | MEDLINE | ID: mdl-32659980

ABSTRACT

Alternaria molds simultaneously produce a large variety of mycotoxins, of which several were previously reported to induce enzymes of phase I metabolism through aryl hydrocarbon receptor activation. Thus, we investigated the potential of naturally occurring Alternaria toxin mixtures to induce Cytochrome P450 (CYP) 1A1/1A2/1B1 activity. Two variants of an extract from cultured Alternaria alternata, as well as the toxins alternariol (AOH), alternariol monomethyl ether (AME), altertoxin I (ATX-I), and altertoxin II (ATX-II), were tested singularly and in binary mixtures applying the 7-ethoxy-resorufin-O-deethylase (EROD) assay in MCF-7 breast cancer cells. Sub-cytotoxic concentrations of the two toxin mixtures, as well as ATX-I, ATX-II and AOH, exhibited dose-dependent enhancements of CYP 1 activity. ATX-I and ATX-II interacted synergistically in this respect, demonstrating the two perylene quinones as major contributors to the extract's potential. Binary mixtures between AOH and the two altertoxins respectively exhibited concentration-dependent antagonistic as well as synergistic combinatory effects. Notably, AME showed no efficacy towards EROD enzyme activity or impact on other toxins' efficacy. Hence, this study provides insights into synergistic and other combinatory effects of Alternaria toxins in natural co-occurrence scenarios in the context of AhR signalling pathway activation in breast cancer cells.


Subject(s)
Alternaria/metabolism , Aryl Hydrocarbon Hydroxylases/metabolism , Breast Neoplasms/metabolism , Mycotoxins/pharmacology , Basic Helix-Loop-Helix Transcription Factors/metabolism , Benz(a)Anthracenes/pharmacology , Breast Neoplasms/drug therapy , Cell Proliferation/drug effects , Cell Survival/drug effects , Drug Synergism , Female , Gene Expression Regulation, Neoplastic/drug effects , Humans , Lactones/pharmacology , MCF-7 Cells , Perylene/analogs & derivatives , Perylene/pharmacology , Receptors, Aryl Hydrocarbon/metabolism
5.
Chem Res Toxicol ; 33(2): 492-504, 2020 02 17.
Article in English | MEDLINE | ID: mdl-32022557

ABSTRACT

Prolonged exposure to mycotoxins, even in subtoxic concentrations, might contribute to modulate pro- or anti-inflammatory cascades and ultimately have long-term consequences on our health. In line, there is an increasing need to describe and comprehend the potential immunomodulatory effects of toxins that can be produced from fungi proliferating even in a domestic environment like, for instance, Alternaria alternata. Taking this as a starting point, we investigated the effects of one of the most potent genotoxic compounds produced by this fungi type, namely altertoxin II (ATXII) on THP-1 macrophages. In noncytotoxic concentrations (0.1-1 µM), ATXII inhibited the activation of the transcription factor NF-κB, and this event was accompanied by significant mitochondrial superoxide production (1 µM ATXII). Both responses seemed dependent on membrane structure and morphology since they were modulated by the coincubation with the cholesterol complexing agent methyl-ß-cyclodextrin (MßCD, 10-50 µM). Moreover, toxicity of ATXII was enhanced by cholesterol load (cholesterol-MßCD). The mycotoxin induced also lipid peroxidation (1-10 µM, ATXII) possibly streaming down at the mitochondrial level and suppressing NF-κB activation in THP-1 macrophages.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Benz(a)Anthracenes/pharmacology , Lipid Peroxidation/drug effects , Macrophages/drug effects , Mitochondria/drug effects , NF-kappa B/antagonists & inhibitors , Anti-Inflammatory Agents/chemistry , Benz(a)Anthracenes/chemistry , Cells, Cultured , Humans , Macrophages/metabolism , Mitochondria/metabolism , Molecular Structure , NF-kappa B/metabolism , Structure-Activity Relationship , THP-1 Cells
6.
Arch Toxicol ; 93(11): 3153-3167, 2019 11.
Article in English | MEDLINE | ID: mdl-31641809

ABSTRACT

Despite the frequent infection of agricultural crops by Alternaria spp., their toxic secondary metabolites and potential food contaminants lack comprehensive metabolic characterization. In this study, we investigated their bioavailability, metabolism, and excretion in vivo. A complex Alternaria culture extract (50 mg/kg body weight) containing 11 known toxins and the isolated lead toxin altertoxin II (0.7 mg/kg body weight) were administered per gavage to groups of 14 Sprague Dawley rats each. After 3 h and 24 h, plasma, urine and feces were collected to determine toxin recoveries. For reliable quantitation, an LC-MS/MS method for the simultaneous detection of 20 Alternaria toxins and metabolites was developed and optimized for either biological matrix. The obtained results demonstrated efficient excretion of alternariol (AOH) and its monomethyl ether (AME) via feces (> 89%) and urine (> 2.6%) after 24 h, while the majority of tenuazonic acid was recovered in urine (20 and 87% after 3 and 24 h, respectively). Moreover, modified forms of AOH and AME were identified in urine and fecal samples confirming both, mammalian phase-I (4-hydroxy-AOH) and phase-II (sulfates) biotransformation in vivo. Despite the comparably high doses, perylene quinones were recovered only at very low levels (altertoxin I, alterperylenol, < 0.06% in urine and plasma, < 5% in feces) or not at all (highly genotoxic, epoxide-holding altertoxin II, stemphyltoxin III). Interestingly, altertoxin I was detected in all matrices of rats receiving altertoxin II and suggests enzymatic de-epoxidation in vivo. In conclusion, the present study contributes valuable information to advance our understanding of the emerging Alternaria mycotoxins and their relevance on food safety.


Subject(s)
Alternaria/chemistry , Benz(a)Anthracenes/metabolism , Mycotoxins/metabolism , Alternaria/growth & development , Animals , Benz(a)Anthracenes/blood , Benz(a)Anthracenes/isolation & purification , Benz(a)Anthracenes/urine , Biological Availability , Body Temperature/drug effects , Body Weight/drug effects , Chromatography, Liquid , Eating/drug effects , Feces/chemistry , Food Contamination/analysis , Limit of Detection , Male , Metabolic Clearance Rate , Metabolic Detoxication, Phase I , Metabolic Detoxication, Phase II , Mycotoxins/blood , Mycotoxins/isolation & purification , Mycotoxins/urine , Rats, Sprague-Dawley , Tandem Mass Spectrometry , Tissue Distribution
SELECTION OF CITATIONS
SEARCH DETAIL
...